Shilpa Medicare Limited (SHILPAMED) Share Price & AI Investment Analysis

Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzal. Track Shilpa Medicare Limited's live NSE:SHILPAMED share price ₹1,021.10 (+6.55%), market cap ₹₹201B, P/E 67.6. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for SHILPAMED — real-time NSE India stock intelligence.